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Abstract 
 
Gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are 
heterodimers of a common  subunit and unique  subunits. Regulation of their levels, primarily 
by GnRH, is critical for reproductive function. Several other hormones modulate gonadotropin 
expression, either independently or by modifying the responsiveness to GnRH. Pituitary 
adenylate cyclase activating peptide (PACAP) is one such hormone. Four-hour treatment of 
female mouse primary pituitary cells by either GnRH or PACAP induced FSH expression, 
while 24-hour treatment repressed FSH.  Both PACAP and GnRH caused FSH secretion into 
the medium. In the gonadotropes, PACAP activates primarily Gs and increases concentration 
of cAMP, while GnRH primarily functions via Gq and increases calcium concentration. Herein, 
we compared PACAP and GnRH signaling pathways that lead to the induction of FSH 
expression. Interestingly, constitutively active Gs represses LH and induces FSH expression, 
while Gq induces both -subunits. We determined that FSH induction by PACAP requires 
functional EPAC, a cAMP sensor protein that serves as a guanine exchange factors for small G 
proteins that then bridges cAMP signaling to MAPK pathway. We further demonstrate that in 
addition to the prototypical small G protein Ras, two members of the Rho subfamily, Rac and 
CDC42 are also necessary for PACAP induction of FSH likely via activation of p38 MAPK 
that leads to induction of cFOS, a critical transcription factor that is necessary and sufficient for 
FSH induction.  Therefore, PACAP-induced cAMP pathway leads to MAPK activation that 
stimulates cFOS induction, to induce the expression of FSH subunit and increase FSH 
concentration.  
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Introduction 
 
Regulation of gonadotropin levels and therefore reproduction depends on the integration of the 
endocrine, paracrine and autocrine signals in the gonadotrope cells of the anterior pituitary 
(Coss, 2018). Gonadotropin hormones, luteinizing hormone (LH) and follicle-stimulating 
hormone (FSH) are heterodimers of a common alpha subunit (α-GSU, Cga) that dimerizes with 
unique beta subunits (LHβ, Lhb and FSHβ, Fshb) (Pierce and Parsons, 1981). β subunits confer 
the biological specificity of LH and FSH and their synthesis is the rate-limiting step for 
production of the mature hormones (Papavasiliou et al., 1986; Kaiser et al., 1997). Synthesis and 
secretion of LH and FSH are primarily regulated by the gonadotropin-releasing hormone 
(GnRH) from the hypothalamus.  GnRH binding to the GnRH receptor, expressed specifically in 
the gonadotrope, causes activation of Gq and G11 types of G-proteins (Stanislaus et al., 
1997), with the subsequent stimulation of phospholipase Cβ, increase in the intracellular calcium 
concentration, and activation of protein kinase C (PKC) and calcium/calmodulin kinase II 
(CamKII), (Liu et al., 2002b; Haisenleder et al., 2003). GnRH receptor signaling also leads to 
activation of the mitogen-activated protein kinase (MAPK) pathways: ERK 1/2, JNK, and p38 
(Roberson et al., 1995; Sundaresan et al., 1996; Liu et al., 2002b), via PKC (Naor, 2009; Ely et 
al., 2011) or via calcium influx through voltage gated calcium channel (Mulvaney et al., 1999).  
Pituitary adenylate cyclase activating peptide (PACAP) is another hypothalamic 
neuropeptide that regulates gonadotropin expression (Counis et al., 2007; Halvorson, 2014). It 
was initially identified as a novel hypothalamic factor that increases adenylate cyclase (AC) 
signaling in the pituitary cultures, as its name suggests (Miyata et al., 1989). PACAP belongs to 
the vasoactive intestinal polypeptide (VIP)-secretin-glucagon superfamily and is widely 
distributed in the brain. It is also expressed in peripheral organs, primarily in the endocrine 
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pancreas, gonads, adrenal, respiratory and urogenital tracts, where it exerts pleiotropic effects 
(Vaudry et al., 2009). PACAP exists as either a 38-amino acid or 27-amino acid form, both 
derived from the same precursor protein encoded by the Adcyap1 gene. Vast majority of PACAP 
protein in most tissues is PACAP38, while PACAP27 represents less than 10% of total PACAP. 
PACAP binds to three receptor subtypes, the PACAP type 1 receptor (PAC1R), the vasoactive 
intestinal polypeptide type 1 receptor (VPAC1R), and the VPAC2R, but the binding affinity is 
much higher for PAC1R than for others (Pisegna and Wank, 1993). All receptors belong to the 
family of G protein-coupled receptors and are expressed in a variety of tissues. The predominant 
receptor for PACAP, PAC1R, couples mainly to Gs protein and induces rapid cAMP 
production, which ultimately activates PKA (Vaudry et al., 2009). cAMP concentration is 
significantly increased following PACAP stimulation of gonadotrope cells as well (Harada et al., 
2007). 
PACAP is also secreted by gonadotropes and folliculostelate cells in the pituitary and 
functions in the autocrine or paracrine manner to modulate response to GnRH (Counis et al., 
2007). GnRH increases the expression of PACAP receptor in the gonadotrope and in turn, 
PACAP potentiates the effect of GnRH (Culler and Paschall, 1991; Purwana et al., 2010). While 
GnRH regulates expression of both β subunits via intermediates, immediate early genes, 
mechanisms of PACAP regulation of gonadotropin β subunits was not thoroughly analyzed. 
GnRH induces LHβ expression through induction of the early growth response-1 (Egr-1) 
transcription factor (Kaiser et al., 2000; Weck et al., 2000). Upon induction, Egr-1 interacts with 
tissue specific and basal factors to regulate the LHβ promoter (Jorgensen et al., 2004; Coss, 
2018). PACAP stimulates the release of LH (Culler and Paschall, 1991; Hart et al., 1992) and 
LHβ expression when administered in a pulsatile manner in rat primary cells (Tsujii and Winters, 
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1995) and continuously in LβT2 cells model (Ferris et al., 2007; Harada et al., 2007). However, 
the promoter elements and transcription factors mediating PACAP effects on LHβ levels are not 
known. 
FSHβ induction by GnRH occurs via activator protein-1 (AP-1) transcription factor, 
cFOS (Coss et al., 2004; Wang et al., 2008). AP-1 also interacts with basal and hormonally-
regulated transcription factors to integrate the responses at the level of the promoter (Coss et al., 
2007; Lamba et al., 2008; Bernard et al., 2010; Ely et al., 2011; Reddy et al., 2013; Roybal et al., 
2014).  Role of PACAP in regulation of FSHβ transcription is not clear.  PACAP increased 
FSHβ expression in LβT2 gonadotrope cell model when administered in either pulsatile manner 
(Kanasaki et al., 2009) or continuously (Harada et al., 2007) and in monkey primary pituitary 
cells (Kawakami et al., 2002). In other studies, however, PACAP dowregulated FSHβ expression 
in rat primary pituitary cells (Tsujii et al., 1994; Tsujii and Winters, 1995) This repression may 
occur via follistatin induction (Winters et al., 1997). Since PACAP expression in the pituitary 
decreases after birth, concomitant with an increase in FSHβ levels, PACAP downregulation of 
FSHβ may be critical during development (Winters and Moore, 2011).  Some inconsistencies 
that exist regarding a role of PACAP in the gonadotrope and gonadotropin expression, may be 
attributed to the level of PACAP receptor expression in different models (Fowkes et al., 2003a). 
Alternatively, the inconsistencies may be explained by crosstalk of pathways, since with 
cotreatment, a signaling pathway may be augmented, while pretreatment may lead to 
downregulation and inability to respond to a subsequent signal. The fact that pretreatment with 
either PACAP or GnRH diminishes the effect of the other can likely be explained by 
downregulation (Fowkes et al., 2003b; Larivière et al., 2008). This hypothesis is strengthened 
with findings from transgenic male mice with permanently elevated PACAP levels that have 
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delayed puberty and decreased gonadotropin levels (Moore et al., 2012).  However, the signaling 
pathways and transcription factors involved in PACAP regulation of FSHβ expression have not 
been determined (Halvorson, 2014). In this manuscript, we sought to determine mechanisms of 
PACAP regulation of FSHβ expression and identify signaling pathways of this regulation and 
compare these with pathways activated by GnRH.  
 
Materials and Methods  
Animals 
 C57BL/6J mice were maintained under a 12-h light, 12-h dark cycle and received food and 
water ad libitum. All experiments were performed with approval from the University of 
California (Riverside, CA) Animal Care and Use Committee and in accordance with the National 
Institutes of Health Animal care and Use Guidelines. Primary pituitary cells in culture were 
obtained as described before (Coss et al., 2005) and treated with 10 nM GnRH or 100 nM 
PACAP for 4 hours or 24 hours, after overnight in the serum free medium. Secretion of 
gonadotropin hormones to the medium was measured using Luminex pituitary panel (Millipore) 
and analyzed using MagPix Luminex instrument (Lainez et al., 2018; Lainez and Coss, 2019), 
according to manufacturers’ instructions. 
Materials 
Immortalized gonadotrope cells line, LβT2 was kindly provided by Pamela Mellon (UCSD, 
California) and cultured as described previously.  The 1kb of the murine FSHβ proximal 
promoter and 1.8kb of the rat LHβ regulatory region linked to luciferase reporter in pGL3 
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plasmid were described previously (Coss et al., 2004; Coss et al., 2005; Roybal et al., 2014; 
Jonak et al., 2017; Jonak et al., 2018). Truncations of FSHβ promoter linked to luciferase were 
described previously (Coss et al., 2004). cFOS expression vector and 1kb cFOS luciferase 
reporter were also described before (Ely et al., 2011; Reddy et al., 2013; Jonak et al., 2018). Gs 
and Gq expression vectors and small G proteins expression vectors were purchased from cDNA 
Resource Center. CREB expression vectors were obtained from Marc Montminy (Salk Institute, 
La Jolla, CA). EPAC expression vectors were obtained from Daniel Altschuler (University of 
Pittsburgh, Pittsburgh, PA). PACAP Receptor expression vector was kindly gifted by Dr. 
Norihito Sintani (Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 
Japan). ELK expression vector was kindly provided by Dr. Andrew Sharrocks (The University of 
Manchester, Manchester, UK). ERK2 and p38 expression vectors were kindly provided by Dr. 
Peiquig Sun (Scripps Institute, La Jolla, CA).  Cells were treated with 10 nM Gonadotropin-
releasing hormone (GnRH, Sigma-Aldrich, St. Louis, MO) or 100 nM Pituitary adenylate 
cyclase activating polypeptide (PACAP 38 Calbiochem, La Jolla, CA). Inhibitors were 
purchased from Calbiochem (La Jolla, CA) and cells pretreated for 30 min with: 1 µM BIM (to 
inhibit PKC); 10 µM H89 (to inhibit PKA); 10 µM KN-93 (KN; to inhibit CamKII); 5 µM 
UO126 (UO; to inhibit MEK1 and activation of ERK1/2), 20 µM SB 202190 (SB; to inhibit 
p38), or 10 µM SP 600125 (JNK; to inhibit JNK), prior to hormone treatment.  
Transient transfections 
Cells were plated one day before transfection in 12-well plates in DMEM containing 10% FBS. 
Cells were transfected using FuGENE 6 (Roche Applied Science, Indianapolis, IN) according to 
the manufacturer’s protocol with 0.5 μg of luciferase reporter plasmid and 0.1 μg of β-
galactosidase, driven by a Herpes virus thymidine kinase (TK) promoter, to control for 
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transfection efficiency. Different batches of LT2 cells express variable levels of PACAP 
receptors and the expression is diminished with passaging, as described before (Fowkes et al., 
2003a; Purwana et al., 2010; Winters and Moore, 2011; Halvorson, 2014). To normalize the 
response to PACAP, we overexpressed PACAP receptor in LT2 cells by adding 0.1 ug of the 
expression vector in the transfection mix. Cells were starved in serum free DMEM containing 
0.1% BSA and penicillin-streptomycin antibiotics the night before harvesting. 4 hours before 
harvesting, cells were treated with 10 nM GnRH, 100 nM PACAP, or vehicle. Inhibitors 
(concentration detailed above) were applied 30 minutes prior to GnRH or PACAP treatment. 
Cells were washed with 1X PBS and lysed with a buffer containing 100nM K-PO4 and 0.2% 
Triton X-100 48 hours after transfection. 20 μl of lysate was loaded into 96-well plates. Both 
luciferase and β-galacatosidase activity were measured with a luminometer (Vertias Microplate 
luminometer from Turner Biosystems / Promega, Madison, WI). 100 μl of a luciferin buffer 
containing 25mM Tris pH 7.8, 15mM MgSO4, 10mM ATP, and 65μM luciferin or 100 μl of 
Accelerator (Applied Biosystems, Foster City, CA) was injected into each well. Lysate for β-
galactosidase assay was first incubated with Tropix Galacto-light substrate (Applied Biosystems, 
Foster City, CA) according to manufacturer’s protocol. Then, 100 μl of catalyst, Accelerator, 
(Applied Biosystems, Foster City, CA) was injected before reading. Each transfection was 
performed in triplicate and repeated three times. Luciferase values in each sample were 
normalized to β -galactosidase values. Results are represented as mean of 3 experiments. 
ANOVA and Tukey’s posthoc test was used to determine statistical significance, p<0.05. 
Whole cell extract, immunoprecipitation and western blot 
LβT2 cells were starved overnight in serum free DMEM containing 0.1% BSA. Cells were 
rinsed with cold 1x PBS then lysed with a buffer containing 20mM Tris pH 7.4, 140mM NaCl, 
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protease inhibitors (Sigma-Aldrich), 1mM PMSF, 10mM NaF, 1% NP-40, 0.5mM EDTA, and 
0.1mM EGTA. Protein concentration was determined using Bio-rad Protein Assay (Bio-rad, 
Hercules, CA) and a standard curve was generated to calculate the concentration. Equal amount 
of proteins were incubated with anti-FLAG or anti-HA antibody linked to agarose beads (Sigma-
Aldrich, St. Louis, MO) for 3 hours. Beads were washed three times with 500μl of cold lysis 
buffer. 30μl of 2x Laemmli sample buffer was added to the beads. 
Equal amounts of protein from whole cell extracts in 4x sample buffer or after 
immunoprecipitation were loaded into an SDS-PAGE gel and proteins were separated by 
gel electrophoresis and then transferred to a polyvinylidene fluoride (PVDF) membrane. 
Membranes were blocked for 1 hour at room temperature in 10% nonfat milk in TBST (20mM 
Tris 7.4, 0.1% Tween, 150mM NaCl, and 0.5% BSA). Membranes were then probed with 
primary antibodies to p-ERK, p-38, p-ELK, or FLAG and HA. After anti-rabbit or mouse 
secondary antibodies linked to horseradish peroxidase (Amersham), enhanced 
chemiluminescence  (ECL) reagent (GE Healthcare, Piscataway, NJ) was used to detect 
complexes. Experiments were repeated three times and representative images shown. 
RT-qPCR 
RNA was obtained with MicroRNA kit (Ambion, Austin TX) according to the manufacturer’s 
instructions.  Contaminating DNA was removed with DNA-free reagent (Ambion, Austin, TX) 
and RNA was reverse transcribed using Superscript IV (Invitrogen, Carlsbad, CA).  Quantitative 
Real-Time PCR was performed in iCycler from Bio-Rad (Hercules, CA), using SYBR Green 
(Bio-Rad, Hercules, CA) and the following primers: LHb forward: 
CTGTCAACGCAACTCTGG; LHb reverse: ACAGGAGGCAAAGCAGC; GAPDH forward: 
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TGCACCACCAACTGCTTAG; GAPDH reverse: GGATGCAGGGATGATGTTC; FSHb 
forward: GCCGTTTCTGCATAAGC; FSHb reverse: CAATCTTACGGTCTCGTATACC; 
under the following conditions: 95 C for 15 min, followed by 40 cycles at 95 C for 15 sec, 54 C 
for 30 sec and 72 C for 30 sec.  Each sample was assayed in triplicate and the experiment was 
repeated 4 times.  A standard curve with dilutions of 10 pg/well, 1 pg/well, 100 fg/well and 10 
fg/well of a plasmid containing LH cDNA was generated in each run with the samples.  In each 
experiment, the amount of LH was calculated by comparing threshold cycle obtained for each 
sample with the standard curve generated in the same run.  Replicates were averaged and divided 
by the mean value of GAPDH in the same sample. Preliminary analysis determined that GAPDH 
does not change with treatment. After each run, a melting curve analysis was performed to 
confirm that a single amplicon was generated in each reaction. ANOVA and Tukey’s posthoc 
test was used to determine statistical significance p<0.05. 
 
Results 
PACAP induces FSH expression 
In order to assess if PACAP regulates gonadotropin  subunits expression, we dispersed primary 
pituitary cells in culture from 4-month old C57Bl/6J female mice and treated them with 10 nM 
GnRH, which serves as a positive control, and with 100 nM PACAP for 4 hours. PACAP 
induced LH (Lhb) expression 2.8 fold and FSH (Fshb) expression 5.2-fold, while GnRH 
induces Lhb 4.6 fold, and Fshb 3.0 fold (Fig. 1A). Thus, induction by PACAP is comparable to 
the induction by GnRH. We then treated the primary pituitary cells for 24 hours to analyze the 
effects of longer treatment. 24-hour treatment with PACAP induced LH (Lhb) expression 1.58 
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fold, while Lhb expression was reduced to 83% after 24-hour GnRH treatment (Fig. 1B). 
PACAP treatment for 24 hours reduced Fshb mRNA to 55% of vehicle treated cells, while 
GnRH treatment diminished Fshb to 52%. As indicated in the introduction, it is possible that 
long-term treatment downregulates the receptors or components of the intracellular signaling 
pathway, which caused a switch from induction to repression of Fshb with both PACAP and 
GnRH treatments.  On the other hand, follistatin is induced by PACAP, which abrogates Fshb 
induction by intra-pituitary activin (Winters et al., 1997; Winters and Moore, 2011). We 
analyzed expression of follistatin (Fst) following 4-hour treatment (Fig. 1C) and following 24-
hour treatment (Fig. 1D) by PACAP or GnRH. 4-hour treatment by PACAP induced Fst 1.3 fold, 
while 4-hour GnRH treatment reduced Fst mRNA to 80% (Fig. 1C). PACAP and GnRH 
treatment for 24 hours induced Fst 1.5 fold and 1.3 fold, respectively. Therefore, follistatin is 
induced by PACAP at both 4 hours and 24 hours to a similar level, while FSH is induced by 
both GnRH and PACAP after 4-hour treatment and repressed after 24-hour treatment in adult 
female mouse pituitary cells.  
We investigated secretion of LH and FSH from female mouse primary pituitary cells 
following 24-hour PACAP or GnRH treatment. LH concentration in the medium increased from 
20 ng/ml to 94.8 ng/ml, a 4.7 fold increase, with PACAP treatment; and to 180 ng/ml, a 9 fold 
increase, with GnRH treatment (Fig. 1E). PACAP increased FSH concentration from 9.9 ng/ml 
to 25.5 ng/ml, a 2.6 fold increase, while GnRH increased FSH in the medium to 41.6 ng/ml, a 4.2 
fold increase (Fig. 1E). Therefore, PACAP, as well as GnRH, caused secretion of both LH and 
FSH.   
To analyze molecular mechanisms of this induction and compare GnRH and PACAP 
signaling pathways, we employed LT2 cells, a model of mature gonadotrope that endogenously 
12 
 
expresses gonadotropin  subunits and responds to hormonal stimuli (Alarid et al., 1996). We 
transiently transfected LH-luciferase and FSH-luciferase reporters that were used previously 
to analyze GnRH regulation of gonadotropin expression (Coss et al., 2005; Jonak et al., 2017; 
Jonak et al., 2018) and treated cells with PACAP and GnRH for 4 hours. PACAP induced LH 
reporter 1.6 fold and FSH reporter 2.8 fold. This induction is also comparable to induction by 
GnRH of 2.4 fold for LH reporter and 2.9 fold for FSH reporter (Fig. 2A).  
Both PACAP receptor (PAC1R) and GnRH receptor (GnRHR) belong to the G-coupled 
7-transmembrane receptor family and activate G-proteins following ligand binding (Halvorson, 
2014; Oride et al., 2018). PACAP, however, primarily activates Gs which leads to an increase 
in cAMP, while GnRH primarily activates Gq/11 which leads to an increase in calcium. To 
ascertain if these G proteins can activate transcription of gonadotropin  subunits, we co-
transfected constitutively active forms of Gs and Gq with gonadotropin  reporters.  
Surprisingly, Gs suppressed LH reporter by 50%, and activated FSH by 2.2 fold. As 
expected, constitutively active Gq induced LH 2 fold and FSH 3.7 fold.  Therefore, PACAP 
and GnRH increase the expression of both gonadotropin  subunits in primary pituitary 
gonadotropes and in LT2 gonadotrope cell model.  
PACAP activates cFOS to induce FSH expression 
Mechanism of FSH mRNA regulation by PACAP has not been explored. Thus, we initiated 
these studies using LT2 cells to examine a role of CREB as a prototypical nuclear target of 
Gs-cAMP-PKA signaling pathway, potentially activated by PACAP. We used multimerized 
cAMP response elements (CRE-luciferase), a consensus binding site for CREB (Mayr and 
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Montminy, 2001), as a positive control. We co-transfected  non-phosphorylatable, mutant CREB 
protein (CREBm, (Struthers et al., 1991)) that serves as a dominant negative, or an empty vector 
control, with CRE-multimer and treated cells with vehicle or PACAP. PACAP induced CRE-
luciferase 4 fold and CREBm abrogated this induction (Fig. 3A). On the other hand, CREBm did 
not affect induction of FSH-luciferase by PACAP (Fig. 3B). We then co-transfected 
constitutively active form of CREB (CA CREB), which induced CRE-luciferase 2.4 fold (Fig. 
3C). CA CREB did not induce FSH-luciferase (Fig. 3D). These results indicate that CREB is 
unlikely to regulate of FSH expression.  
 To determine the elements in the FSH promoter that PACAP may employ for induction, 
we used truncation analysis, and determined that PACAP induction of FSH is abrogated with a 
truncation from -95 to -60 base pairs from the transcriptional start side (Fig. 4A). This is the 
same region necessary for the FSH responsiveness to GnRH, which induces FSH via 
induction of cFOS that binds AP-1 site at -76 (Coss et al., 2004; Wang et al., 2008). Therefore, 
we transfected a reporter with the mutation in the -76 AP-1 site and compared its induction to the 
induction of the wild type reporter. -76 site mutation diminished induction of the FSH reporter 
by PACAP (Fig. 4B). Then, we analyzed if PACAP induces cFOS in the gonadotrope cells, since 
PACAP increases cFOS expression in the brain (Meloni et al., 2016). We determined that cFOS 
is induced at the mRNA (not shown) and protein level (Fig. 4C) following PACAP treatment. 
PACAP also induces cFOS reporter 9.7 fold (Fig. 4D). Since previously we have shown that 
overexpression of cFOS is sufficient to induce FSH in the LT2 cells (Ely et al., 2011; Jonak et 
al., 2018), we postulate that PACAP induces FSH via cFOS as well.  
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PACAP uses EPAC to activate MAPK pathway 
 Since GnRH and PACAP may activate FSH transcription via the cFOS intermediate 
gene, but they bind receptors that preferentially activate different G proteins, we wanted to 
analyze signaling pathways activated by PACAP and compare them to GnRH-activated signaling 
pathways. Our previous studies determined that GnRH signals primarily via CamKII activation 
following intracellular calcium increase, with some contribution of ERK 1/2 and p38 pathways, 
to activate FSH and cFOS transcription (Ely et al., 2011). To analyze PACAP signaling 
pathways necessary for induction of cFOS and FSH we used inhibitors and determined that 
PACAP does not utilize CamKII (Cam), but that the activity of PKA, ERK 1/2 and p38 is 
necessary for maximal induction of FSH (Fig. 5A) and cFOS (Fig. 5B) by PACAP.  
 To determine if PACAP activates ERK 1/2 and p38, we analyzed their phosphorylation 
with western blots following vehicle (C), PACAP (P) or GnRH (G) treatments. These 
experiments determined that PACAP treatment, as well as GnRH, leads to phosphorylation and 
activation of ERK 1/2 (Fig. 6), which is in agreement with previous reports (Fowkes et al., 
2003b; Purwana et al., 2010). We further determined that PACAP activates p38 as well (Fig. 6). 
Transcription factor ELK is a nuclear target of ERK 1/2 and p38 kinases, which when 
phosphorylated forms an active complex with SRF to activate transcription of cFOS (Sharrocks, 
2002). ELK is also phosphorylated following PACAP and GnRH (Fig. 6).  Therefore, PACAP 
uses classical growth factor pathway, via MAPK phosphorylation of ELK to activate expression 
of cFOS, and subsequently FSH.  
 To determine how PACAP activates MAPK pathway, we postulated that it may use 
exchange protein directly activated by cAMP (EPAC). EPAC is a guanine nucleotide exchange 
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factor that is activated by cAMP and in turn activates Ras superfamily of small GTPases, which 
then leads to MAPK activation (Lewis et al., 2016; Robichaux and Cheng, 2018).  We obtained 
two different forms of dominant negative EPAC: dn1, created by mutation of the arginine 
residue at the position 279 to glutamate which prevents cAMP binding, and dn2, that lacks Ras 
association domain (Hochbaum et al., 2008); and co-transfected them with FSH (Fig. 7A) and 
cFOS (Fig. 7B) reporters. Cells were treated with PACAP (black bars) or GnRH (gray bars). 
Dominant negative EPACs diminished induction of FSH and cFOS by PACAP, but had no 
effect on the induction by GnRH.  We previously determined that CamKII is necessary for 
GnRH induction of FSH and cFOS (Ely et al., 2011), and here we transfected dominant 
negative CamKII to assess its necessity for PACAP induction of FSH and cFOS. As shown 
before, dominant negative CamKII is necessary for induction of FSH (Fig. 7C) and cFOS (Fig. 
7D) by GnRH, but not by PACAP. Taken together our results indicate that while GnRH activates 
FSH and cFOS transcription via CamKII and MAPK, PACAP induces FSH and cFOS via 
MAPK pathways that are activated by cAMP-mediated EPAC activation. 
 As stated above, EPAC molecules activate small GTPases by exchanging GDP for GTP 
(Robichaux and Cheng, 2018). Thus, we assessed several small G proteins for their roles in 
FSH and cFOS induction. First, we transfected constitutively active forms to determine which 
small G proteins can activate transcription of FSH and cFOS reporters. Constitutively active 
Ras, Rac and CDC42 activate transcription of FSH (Fig. 8A) and cFOS (Fig. 8B). We also 
analyzed which of these small G proteins can phosphorylate ERK1/2 and p38 by western blots. 
ERK2 isoform is more abundant than ERK1 (Shin et al., 2013), and out of four p38 isoforms, 
p38 plays a role in normal physiological processes while p38 is mostly involved in cell 
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responses to stress, and  and  have low abundance (Askari et al., 2007). Thus, we co-
transfected FLAG-tagged ERK2 and HA-tagged p38 with constitutively active forms of small 
G proteins. ERK2 is activated by Ras, while p38 is activated by Ras, Rac and CDC42 in the 
gonadotrope cell model (Fig. 8C). 
We then determined which of these small G proteins are necessary for PACAP and 
GnRH induction of FSH and cFOS by transfecting dominant negative mutants. Consistent with 
our previous results that GnRH stimulation leads to CamKII activation that is necessary for 
FSHinduction, small G proteins are not necessary for FSH induction by GnRH (Fig. 9A). For 
PACAP induction of FSH, however, Ras, Rac and CDC42 are necessary (Fig. 9A). Rho, Rac 
and CDC42 are necessary for maximal induction of cFOS by either GnRH or PACAP (Fig. 9B).  
Our results demonstrate the necessity of several small G proteins, which may be targets of EPAC 
signaling following cAMP increase, for induction of FSH by PACAP.  Taken together, our 
results indicate that GnRH activates CamKII, via increase in intracellular calcium by Gq-
PLC, to induce cFOS and FSH, while PACAP activates EPAC via increase in cAMP by Gs-
adenylate cyclase, that leads to activation of MAPK through several small G proteins, that in turn 
induces cFOS and FSH (Fig. 10).  
 
Discussion 
Concentrations of pituitary gonadotropins, LH and FSH, are regulated primarily by the 
hypothalamic peptide GnRH, which stimulates their synthesis and secretion. Other factors, such 
as gonadal steroids and gonadal peptides such as inhibin, or pituitary-expressed peptides that 
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function in autocrine or paracrine manner, such as activin and follistatin, influence gonadotropin 
levels, directly or by modulating the responsiveness to GnRH (Coss, 2018). In addition, PACAP, 
a product of the Adcyap1 gene expressed in the hypothalamus and the pituitary, also regulates 
gonadotropin synthesis and release, both alone and in cooperation with GnRH (Winters and 
Moore, 2011; Halvorson, 2014). In this manuscript, we address the mechanisms of this 
regulation by analyzing signaling pathways and promoter elements activated by PACAP and 
compare them to GnRH. Although PACAP regulates expression of all three gonadotropin 
subunits, promoter elements responsive to PACAP were only analyzed for the common 
-subunit (Attardi and Winters, 1998; Burrin et al., 1998), and in this manuscript we analyzed 
the induction of FSHand promoter elements therein. We determine that both PACAP and 
GnRH stimulate FSH expression after 4-hour treatment of primary pituitary cells from the 
female mouse, but repress FSHafter 24 hours.  We then analyzed pathways that lead to 
induction of FSH and future studies will analyze mechanisms of repression following 24-hour 
treatment. Similar to GnRH, PACAP induces FSH via induction of cFOS. We further 
investigate roles of small G proteins and EPAC molecules in both GnRH and PACAP signaling 
in order to explain the mechanisms of cAMP-activated pathways stimulated by PACAP receptor 
activation, bridging to MAPK pathways and cFOS and FSH promoters.  
PACAP, expressed in the hypothalamus, may be secreted from the nerve terminals within 
the median eminence and carried by the portal circulation to stimulate the pituitary, and act as a 
hypophysiotropic neurohormone. Alternatively, in the pituitary PACAP is expressed by the 
gonadotrope and may function in an autocrine manner, and by the folliculostellate cells and may 
function in the paracrine manner. Either way, PACAP regulates gonadotropin hormone synthesis 
and gonadotrope responsiveness to GnRH. Some studies determined that PACAP stimulates all 
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three gonadotropin subunits expression, including FSH(Kawakami et al., 2002; Harada et al., 
2007; Kanasaki et al., 2009; Purwana et al., 2010). Others, on the other hand reported that while 
PACAP induces -GSU and LH, it represses FSH in rat primary pituitary culture (Tsujii and 
Winters, 1995; Winters et al., 1996). Repression of FSH by PACAP is indirect via induction of 
follistatin and may be critical during development (Winters and Moore, 2011). In agreement, we 
also determined that PACAP induces follistatin expression, albeit to a relatively low level. We 
found that PACAP induces both LH and FSHin primary pituitary cells from female mice after 
4 hours of treatment, but represses FSH after 24 hour treatment although LH mRNA remains 
elevated compared to controls. Several possibilities can be proposed to explain the differences in 
our study and studies that demonstrated repression of FSH.  First, the difference may be due to 
the physiological state of the animals from which the pituitaries were extracted or to the stress 
level the animals experienced during transport or procedure.  For example, different levels of 
steroid hormones can contribute to the differences in results, since several studies that reported 
repression of FSH used gonadectomized animals that lack sex steroids.  Second, the duration of 
the treatment is different.  As discussed in the introduction, duration of treatment may augment 
or dowregulate the pathway involved in crosstalk (McArdle and Counis, 1996; McArdle et al., 
1996). We used acute, 4-hour treatment to prevent downregulation of signaling pathways. 
Indeed, in our studies as well, 24-hour treatment by either PACAP or GnRH repressed FSH. 
Third, the studies that observed repression of FSH likely had a higher level of folliculostellate 
cells due to longer culture prior to the hormone treatment.  These studies reported that the cells 
were cultured for 3 days prior to the 9-hour treatment. However, in primary pituitary cultures, 
secretory cells are rapidly overgrown by folliculostellate cells, which secrete follistatin, a potent 
FSH repressor (Kawakami et al., 2002).  Our studies were performed in freshly isolated cells to 
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minimize changes during culture. Fourth, there are significant species differences in regulation of 
gonadotropin hormones (Bernard et al., 2010). Finally, sex differences may play a critical role 
since we used primary cells from adult female mice, while previous studies used male rat 
pituitary cells. Gonadotropin  subunits in particular exhibit substantial sex differences in their 
levels of expression (Bjelobaba et al., 2015; Kreisman et al., 2017) 
PACAP signaling in the gonadotrope cells causes an increase in cAMP via Gs 
activation of adenylate cyclase (Harada et al., 2007; Winters and Moore, 2007). Although some 
studies have shown increase in calcium, calcium does not play a role in PACAP induction of 
gonadotropin subunits (Attardi and Winters, 1998; Burrin et al., 1998), indicating that PACAP 
functions primarily via cAMP, as expected from the Gs activation by PACAP receptor. We 
investigated roles of Gs, activated by PACAP and Gq, activated by GnRH, by transfecting 
constitutively active forms of these G proteins. As expected Gq induced both LH and FSH, 
while surprisingly, Gs repressed LH and induced FSHThis was unexpected, since PACAP 
induces LH, and will require further investigations which are beyond the scope of this report 
that focuses on FSH induction.  The most common nuclear target of the cAMP pathway is 
CREB transcription factor, but we could not find any evidence of CREB involvement in the 
FSH expression. Our results concur with previous findings that PACAP activates MAPK 
pathways (Fowkes et al., 2001; Harada et al., 2007), which lead to FSH induction. This poses a 
question of how does cAMP activate MAPK pathways in the gonadotrope. One potential 
mediator is EPAC that we addressed here. We show that functional EPAC is necessary for FSH 
induction by PACAP, but not by GnRH. 
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Several guanine exchange factors (GEF) interact with trimeric G proteins and activate 
small G proteins that in turn activate MAPK cascade (Goldsmith and Dhanasekaran, 2007). 
EPAC (exchange protein directly activated by cAMP) is a cAMP sensor protein that serves as a 
GEF for small G proteins (Quilliam et al., 2002). Gs activation and subsequent generation of 
cAMP activates EPAC, which elicits GDP–GTP exchange in Rap-1 small G protein. The 
activated GTP-bound Rap-1 activates B-Raf and the downstream MAPK (Goldsmith and 
Dhanasekaran, 2007).  This may play a role in Gs induction of FSH. Gs-mediated cAMP–
PKA signaling pathway can also inhibit MAPK pathways, which entails serine phosphorylation 
of another Raf isoform, C-Raf, at a residue that prevents Ras-mediated phosphorylation and 
activation (Goldsmith and Dhanasekaran, 2007). This may play a role in the repression of LH 
by Gs that we observed and will be explored further.  EPAC proteins bind to cAMP with high 
affinity and activate the Ras superfamily of small GTPases (Bos, 2006; Robichaux and Cheng, 
2018).  EPAC was originally identified as a GEF for Rap-1 GTPases, which are activated by 
cAMP independent of PKA (Kawasaki et al., 1998). Later studies determined that EPAC can 
activate other branches of Ras superfamily as well (Shariati et al., 2016). There are two isoforms 
of EPAC, EPAC1 and EPAC2, products of independent genes in mammals. While EPAC1 is 
ubiquitously expressed in all tissues, EPAC2 is more limited in its tissue distribution (Lewis et 
al., 2016) and we concentrated our studies on EPAC1. We determined that EPAC1 is necessary 
for PACAP induction of FSH.  
There are five main braches of the small G protein superfamily: Ras, Rho, Ran, Arf and 
Rab and each has its cohort of regulatory proteins, such as GEFs, which promote small G protein 
activation by exchanging GDP for GTP (Loirand et al., 2013). The Ran, Arf, Rab family are 
localized in the specific subcellular compartments and regulate nuclear, Golgi and ER 
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trafficking, and thus, were not investigated in our studies. Because Ras and Rho families are 
involved in receptor signaling, we focused on the members of these groups. The Ras family 
contains several Ras and Rap isoforms, while Rho contains Rho, Rac and CDC42 isoforms 
(Rossman et al., 2005; Hall, 2012). They each can interact with 20-30 downstream proteins, 
regulating numerous signaling pathways as of yet unclear specificity (Hall, 2012). They can also 
activate each other, increasing complexity further. We demonstrate that Rac and CDC42 activate 
p38 in the gonadotrope cells, consistent with previous reports using Cos-1 cells (Gallo and 
Johnson, 2002). We also show that they are involved in the cFOS and FSH induction by 
PACAP likely via p38 or through activation of SRF (Miralles et al., 2003), since we have shown 
previously that SRF is sufficient and necessary for cFOS induction by GnRH (Ely et al., 2011). 
Therefore, Rac and CDC42 may be the targets of cAMP-EPAC pathway activated by PACAP 
that leads to FSH induction.  
Herein, we compared GnRH and PACAP signaling pathways that lead to induction of 
FSH. Future studies will analyze whether downregulation of FSH by 24-hour treatment is due 
to the follistatin induction, or due to down-regulation of secondary messengers and signaling 
pathways. In our studies, follistatin was induced at both 4-hour treatment and 24-hour treatment, 
while FSH is induced after 4 hours and repressed after 24 hours. Our previous investigations of 
GnRH signaling pathways that activate gonadotropin gene expression, and PACAP signaling 
pathways in this report, reveal critical signaling molecules necessary for  subunit induction. 
GnRHR activates downstream signaling pathways through activation of trimeric Gαq/11 
proteins. The Gαq pathway leads to gonadotropin expression via CamKII activation of SRF 
transcription factor that induces both Egr-1 (Witham et al., 2013) and cFOS (Ely et al., 2011) and 
through them gonadotropin  subunits (Coss, 2018). CamKII activation of SRF had been 
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reported in neuronal cells, and was also sufficient for cFOS induction. In neurons, this pathway 
is activated by depolarization mediated-calcium influx, while growth factor induction of cFOS in 
the same cells requires the MAPK pathway. In the gonadotrope cells, GnRH causes calcium 
influx that is necessary for cFOS induction (Mulvaney et al., 1999; Liu et al., 2002a). Thus, 
GnRH induction of cFOS is similar to cell depolarization rather than to hormone/growth factor 
signaling. GnRH activation of the MAPK pathway augments this activation via phosphorylation 
of ELK-1 that interacts with SRF. PACAP activation of Gαs, a trimeric G protein that leads to 
activation of adenylate cyclase and cAMP formation, activates EPAC that links Gs-adenylate 
cyclase-cAMP pathway to MAPK signaling via small G proteins, in particular Rac and CDC42. 
MAPK, ERK1/2 and p38, activate cFOS and FSH transcription via ELK-1 phosphorylation. 
 
Conclusion  
Both GnRH and PACAP induce FSH following 4-hour treatment and both repress FSH after 
24-hour treatment of female mouse primary pituitary cells. FSH is secreted from these cells in 
response to either GnRH or PACAP. The repression after 24 hours may occur due to the 
induction of follistatin or stem from the downregulation of receptors and second messenger 
depletion. In this manuscript, we further analyzed that mechanism of induction. Signaling 
pathways activated by PACAP and GnRH converge on the expression of cFOS transcription 
factor that is necessary for FSH induction (Fig. 10). While GnRH activates Gq and causes an 
increase of intracellular calcium that activates CamKII and MAPK, PACAP activates Gs that 
increases cAMP, which is turn activates MAPK via EPAC and small G proteins.  
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Figure legends 
Fig. 1. PACAP induces LH and FSH in mouse pituitary cells. Primary pituitary cells from 
16-week old female mice were dispersed by enzymatic dissociation and treated with GnRH (G) 
or PACAP (P) for 4 hours in serum free medium (A and C) or for 24 hours in serum free medium 
(B and D). Total mRNA was reverse transcribed and qPCR performed to assess levels of Lhb 
(LH) and Fshb (FSH) mRNAs (A, B) and Fst (Follistatin) mRNA (C, D). E, Concentration of 
LH and FSH in the medium after 24-hour treatment with vehicle (ctr), 100 nM PACAP (P) or 10 
nM GnRH (G) was analyzed using Luminex assay. Experiments were performed three times.     
* indicates significant induction by hormones compared to vehicle treated cells, while # indicates 
significant repression (p<0.05, ANOVA and Tukey’s posthoc test).  
 
Fig. 2. PACAP induces LH and FSH in LT2 cells. A, LT2 cells were transfected with 1.8 
kb LH-luciferase reporter and 1 kb FSH-luciferase reporter and treated with GnRH or PACAP 
for 4 hours. Luciferase values were normalized to -galactosidase and results presented as fold 
induction from vehicle treated cells. Significant induction by hormones compare to vehicle 
treated cells (p<0.05, ANOVA and Tukey’s posthoc test) is indicated with * . B, Cells were co-
transfected with constitutively active Gs or Gq expression vectors and after 48h, expression of 
the reporters in cells with G was compared to the expression in cells co-transfected with empty 
vector control. Significant induction of the reporter expression in G-expressing cells compared 
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to empty vector transfected control cells is indicated with *, while significant repression is 
indicated with # (p<0.05, ANOVA and Tukey’s test).  
 
Fig. 3. CREB induces CRE element but not FSH reporter. Reporter containing 4 copies of 
the cAMP-Response element (CRE), a consensus binding site for CREB (A, C) fused to 
luciferase gene, or a reporter containing 1 kb FSH regulatory region, FSH-luciferase (B, D) 
was co-transfected with the dominant negative CREB mutant (CREBm; A, B) or with the 
constitutively active (CA) CREB mutant (C, D) in LT2 cells.  Cells were treated with vehicle or 
PACAP for 4h to assess a role for CREB in reporter expression. * indicates significant reporter 
induction with PACAP (A, B) or with CA CREB (C, D).  
 
Fig. 4.  PACAP induction maps to the AP1 site in the FSH promoter. A, To map the region 
necessary for PACAP induction, different lengths of the FSH reporter were transfected and cell 
treated with PACAP for 4 hours after overnight starvation. The results are represented as fold 
induction by PACAP from vehicle-treated cells for each truncation. # indicates significantly 
lower fold induction of the truncation compared to the previous longer truncation. Results 
represent the mean ± SEM of 3 independent experiments each performed in triplicate.  B, Two 
bp mutation in the -76 AP1 response element was introduced into the reporter and its induction 
by PACAP compared to the induction of the wild-type reporter.  Results are presented as fold 
induction. Significantly different fold induction in the cells with AP1 mutation versus the cells 
transfected with wild-type reporter is marked with #.  C, Western blots demonstrate induction of 
cFOS protein following PACAP treatment of LT2 cells for times indicated above each lane. D, 
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1kb cFOS-luciferase reporter was transfected in LT2 cell and * indicates significant induction 
by PACAP treatment compared to vehicle treated cells.  
Fig. 5.  Inhibition of MAPK diminishes PACAP induction of FSH. LT2 cells were 
transfected with 1 kb FSH-luciferase (A) or 1 kb cFOS luciferase (B) and were pretreated for 
30 minutes with 10 µM H89 (to inhibit PKA); 1 µM BIM (to inhibit PKC); 10 µM KN-93  (to 
inhibit CamKII, Cam); 5 µM UO126 (to inhibit MEK1 and activation of ERK1/2), 20 µM SB 
202190 (to inhibit p38), or 10 µM SP 600125 (to inhibit JNK). Cells were treated with 100 nM 
PACAP for 4 hours. Luciferase values in each sample were normalized to β-galactosidase 
values. Experiment was repeated 3 times in triplicate and mean +/- standard error is presented. 
Results were represented as fold induction by PACAP from the vehicle control treated cells with 
the same inhibitor. # represents significant decrease in fold induction from PACAP treated cells 
without inhibitor, p<0.05 determined by ANOVA and Tukey’s posthoc test. 
Fig. 6. PACAP activates p38, ERK1/2 and ELK.  LT2 cells were transfected with Flag-
tagged ERK2 or ELK, or HA-tagged p38. After treatment with GnRH or PACAP, lysates were 
precipitated with anti-Flag or anti-HA beads and western for phosphorylated forms of ERK2, 
p38 and ELK performed. Experiment was repeated 3 times and representative images shown.  
Fig. 7. EPAC plays a role in PACAP induction of FSH.  LT2 cells were co-transfected with 
FSH reporter (A, C) or cFOS reporter (B, D) and empty vector control (control), or dominant 
negative EPAC mutants (dn EPAC; A, B)) or dominant negative CamKII mutant, used 
previously (C, D). Cells were treated with vehicle (white bars), PACAP (black bars) or GnRH 
(grey bars) to assess a role for EPAC or CamKII in reporter induction by PACAP or GnRH. 
Luciferase levels in each well were normalized to -galactosidase values.  Significantly lower 
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expression in the reporter induction by PACAP or GnRH due to the presence of the dominant 
negative mutant compared to the empty vector control is indicated with #, determined by 
ANOVA and Tukey’s posthoc test.  
 
Fig 8. Several small G proteins induce FSH. LT2 cells were co-transfected with FSH 
reporter (A) or cFOS reporter (B) and constitutively active mutations of small G proteins. 
Reporter expression was analyzed 48h later. Luciferase values in each sample were normalized 
to β-galactosidase values. Results are presented as mean of three independent experiments 
performed in triplicate and * indicates significant induction of the reporter by a G protein 
compared to expression with empty vector control, determined by ANOVA and Tukey’s posthoc 
test. C, Flag-tagged ERK2 or HA-tagged p38 were co-transfected with constitutively active 
small G proteins.  ERK2 or p38 were precipitated with anti-Flag or anti-HA beads respectively. 
Anti-phospho-ERK1/2 and anti-phospho-p38 antibodies were used to assess activation of these 
proteins. Experiment was repeated three times and representative images shown.  
 
Fig. 9. Ras, Rac and Cdc42 are involved in PACAP induction of FSH.  FSH reporter (A) 
or cFOS reporter (B) was co-transfected with empty vector control (control) or dominant 
negative mutants (dn) of small G proteins. LT2 cells were then treated with vehicle (white 
bars), PACAP (black bars) or GnRH (grey bars) to assess small G protein role in reporter 
induction. Luciferase values in each sample were normalized to β-galactosidase values. 
Significantly lower expression of the reporter induction by PACAP or GnRH due to the presence 
of the dominant negative mutant, compared to the empty vector control (control) is indicated 
with #, determined by ANOVA and Tukey’s posthoc test.  
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Fig. 10. Signaling pathways involved in FSH induction by GnRH and PACAP. GnRH 
signals via Gq that causes an increase in the intracellular calcium. This increase activates 
CamKII that is sufficient and necessary for FSH induction. MAPK is also activated, and 
contributes to the induction of FSH by GnRH maybe by extending the cFOS half-life, as we 
have shown before, or by potentiating induction by GnRH via ELK1 phosphorylation. PACAP 
activates Gs which leads to an increase in cAMP concentration that activates EPAC. EPAC, in 
turn, leads to activation of several small G proteins that activate MAPK pathways, in particular 
ERK1/2 and p38 that via cFOS induction induce FSH.   
 
 
 
 
 
 
 
Highlights  
 
1. PACAP induces gonadotropin  subunits expression in mouse primary pituitary cells 
2. PACAP induces LH and FSHsecretion from female mouse primary pituitary cells  
3. Gs induces FSH but represses LH, while Gq induces both  subunits 
4. PACAP induces FSH via EPAC that bridges cAMP to MAPK 
5. Ras, Rac and CDC42 small G proteins contribute to FSH inductions by PACAP 
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